Pharmafile Logo
Pharmafocus logo
Advanced Search
jj_sign_on_wall

Indian authorities seize J&J Baby Powder in response to Reuters report

December 19, 2018
Research and Development Cancer, India, J&J, JJ, asbestos, baby powder, regulation

Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after …

News
gsk_china_8

GSK and Pfizer combine healthcare units in multibillion dollar deal

December 19, 2018
Research and Development GSK, OTC, Pfizer, healthcare, merger

American multinational Pfizer and British firm GlaxoSmithKline are set to combine their consumer healthcare units in a venture worth billions. …

News

Novartis inks deal with Canadian cannabis firm Tilray

December 18, 2018
Research and Development Marijuana, Novartis, Sandoz, Tilray, cannabis

Shares in Canadian cannabis company Tilray jumped by more than 11% today after the British Columbia-based firm announced its entry …

News
82958bfc7df1311fd17a008495fc-1456375

Pharma in 2018: Looking back, looking forward

December 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2018, Alligator Bioscience, Eisai, Gilead, Mundipharma, pharma

2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 …

Feature

NHS spends £26 million on consultancy

December 18, 2018
Manufacturing and Production BMA, Consultancy, Jobs, NHS, health

Private consultancy firms were paid at least £26 million as part of a reorganisation of the NHS, in what has …

News

Celltrion and Teva’s Herceptin biosimilar secures FDA approval in breast cancer

December 18, 2018
Manufacturing and Production, Sales and Marketing Herceptin, Herzuma, Teva, celltrion, pharma

Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by …

News

Eli Lilly’s Taltz shows superiority over AbbVie’s Humira

December 18, 2018
Manufacturing and Production Eli Lilly, Humira, Taltz, arthritis, immune system

A study has found that Eli Lilly’s Taltz (ixekizumab) met the primary, and all secondary endpoints, in patients with active …

News
johnson_and_johnson_jj

J&J announces $5bn share repurchase

December 18, 2018
Manufacturing and Production J&J, JJ, Shares, asbestos, baby powder, reuters, scandal

New Jersey-based pharma firm Johnson & Johnson plans to buy back $5 billion in shares after news agency Reuters released …

News
pharmafile_autumn_2018

The Autumn 2018 edition of Pharmafile is available to read online now!

December 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing immunology, infectious diseases, pharma, pharmafile, rare diseases

The Autumn 2018 edition of Pharmafile, our long-running bi-annual guide to the latest trends, projections and thought leadership positions in …

News

NHS overcrowding leads to ambulances being turned away

December 17, 2018
Sales and Marketing Hopsitals, NHS, UK, health, politics

NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above …

News
novartis_outside_1

Novartis withdraw marketing application for heart drug

December 17, 2018
Sales and Marketing CHMP, EMA, MI, Novartis, pharma

Swiss multinational Novartis has withdrawn a European Medicines Agency (EMA) marketing application for canakinumab for the prevention of serious events …

News
bms_nassau_park_new_jersey

CHMP approve Bristol-Myers Squibb’s Sprycel for paediatric patients with Ph+ ALL

December 17, 2018
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Sprycel, all

New Jersey-based firm Bristol -Myers Squibb today announced that the Committee for Medicinal Products for Human Use (CHMP) of the …

News
4768764591_9e4f7f0eb8_z

No-deal Brexit stockpiling puts pressure on supply chain

December 17, 2018
Sales and Marketing brexit, no-deal, pharma, pricing, supply chain

The stockpiling of medicines in preparation for a no-deal Brexit is putting pressure on the supply chain and causing shortages …

News

J&J shares plummet after asbestos cover up allegations emerge

December 17, 2018
Sales and Marketing J&J, JJ, Johnson & Johnson, asbestos, reuters

Shares in American healthcare firm Johnson & Johnson plummeted on Friday after news agency Reuters reported that the New Jersey-based …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10

Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …

News
scotland-1761292_960_720

‘Significant’ health outcomes gap still exists in Scotland

December 14, 2018
Medical Communications NHS, Scotland, UK, health, inequality

There is a significant gap in health outcomes between the most and least deprived areas of Scotland, a Scottish government …

News

Data reveals November’s performance was worst on record for NHS

December 14, 2018
Medical Communications NHS, NHS England, UK, funding, investment, wait times

November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …

News
york-492566_960_720

York-based biotech expands premises after $2.2 million investment

December 14, 2018
Medical Communications UK, aptamer, biotech, funding, investment, york science park

The York-based Aptamer Group is set to expand its premises after securing $2.2 million in overseas investment in June of …

News

Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m

December 13, 2018
Business Services GI, IBS, basuch, cnstipation, synergy pharma

Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch …

News
msd

MSD announced collaboration with Brazilian non-profit over development of dengue vaccine

December 13, 2018
Business Services, Medical Communications, Research and Development Dengue fever, HPV, hepatitis a, vaccines, virus

US firm Merck & Co have announced a collaboration with the Brazilian non-profit Instituto Butantan, with the intention of developing …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026